Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Withdrawal and Everolimus Monotherapy in Liver Transplant
NCT02736227Completed
- Sponsor
- Northwestern University
- Start
- Mar 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of everolimus in Liver transplant rejection, sponsored by Northwestern University. Primary endpoint: Amount of Treg Cells Observed in Peripheral Blood in Patients With and Without Rejection. Started Mar 2016; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02736227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736227.